-
Company Insights
Innovation and Patenting activity of Verve Therapeutics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Verve Therapeutics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
NewKingfisher – Digital Transformation Strategies
Kingfisher sells home improvement products and offers home improvement services to consumers and trade professionals in eight European countries. It operates under the B&Q, Screwfix, Castorama, Brico Dépôt, Koçtaş, and TradePoint retail banners. In addition to retailing, Kingfisher manufactures several home improvement products such as cabinets, taps, bathroom furniture, sinks, cutting discs, drills, and modular storage among others. These products are sold under Kingfisher’s own exclusive brand names, which include Cooke & Lewis, Erbauer, Evalux, GoodHome, LAP, Myko, Verve, Klikstrom,...
-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Product Insights
Atherosclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Arteriosclerosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Arteriosclerosis - Drugs In Development, 2023’, provides an overview of the Arteriosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arteriosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Renal Denervation Catheters Pipeline Market Report Overview Renal denervation is also known as renal sympathetic denervation (RSD). It is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension. The Renal Denervation Catheters pipeline market research report provides comprehensive information about the Renal Denervation Catheters pipeline products with a comparative...